Hrt Financial LP Pds Biotechnology Corp Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$2.55 - $4.02 $97,172 - $153,190	38,107 New	38,107 $111,000
Q1 2023 May 12, 2023	BUY	$5.68 - $11.99 $502,026 - $1.06 Million	88,385 New	88,385 $543,000
Q1 2022 May 16, 2022	SELL	$4.78 - $8.43 $166,277 - $293,245	-34,786 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.76 - $14.35 $269,939 - $499,179	34,786 New	34,786 $281,000

4.32M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $47M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.